# XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1)

> **NCT00676520** · — · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 8053 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** XIENCE V® Everolimus Eluting Coronary Stent

## Key facts

- **NCT ID:** NCT00676520
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 8053 (ACTUAL)
- **Last updated:** 2012-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00676520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00676520, "XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00676520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*